Validation of a PCR method for the detection of mycoplasmas according to European Pharmacopoeia section 2.6.7

Biologicals

Volumn 38, Issue 2, 2010, Pages 232-237

  Zhi, Yan ^a   Mayhew, Amy ^a   Seng, Natalie ^a   Takle, Garry B ^a  

^a WUXI APPTEC   (China)

Author keywords

Biosafety; European Pharmacopoeia; Mycoplasma; PCR method; Validation

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; CONTROLLED STUDY; CULTURE TECHNIQUE; DRUG INDUSTRY; EUROPE; INTERMETHOD COMPARISON; MYCOPLASMA; NONHUMAN; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VALIDATION PROCESS;

ANIMALS; BACTERIOLOGICAL TECHNIQUES; CHO CELLS; CRICETINAE; CRICETULUS; DNA, BACTERIAL; EUROPE; HUMANS; LIMIT OF DETECTION; MYCOPLASMA; MYCOPLASMA INFECTIONS; PHARMACOPOEIAS AS TOPIC; POLYMERASE CHAIN REACTION; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

MYCOPLASMA; MYCOPLASMATALES;

EID: 77950691983     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.11.003     Document Type: Article

References (15)

1. European Pharmacopoeia. 6.1, section 2.6.7 Mycoplasmas; Revised January 2008.
2. Razin S., Yogev D., Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998, 62:1094-1156.
3. Food and Drug Administration (FDA) Center for biologics evaluation and research. Points to consider in the characterization of cell lines used to produce biologicals 1993, US Department of Health and Human Services, Rockville, MD.
4. Japanese Pharmacopoeia XIV. Mycoplasma testing for cell substrates used for the production of biotechnological/biological products. 9. p. 1316-9.
5. Eldering J.A., Felten C., Veilleux C.A., Potts B.J. Development of a PCR method for Mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins. Biologicals 2004, 32:183-193.
6. Wong-Lee J.G., Lovett M. Rapid and sensitive PCR method for identification of Mycoplasma species in tissue culture. Diagnostic molecular microbiology principles and applications 1993, 257-260. American Society for Microbiology, Washington, DC. D.H. Persing, T.F. Smith, F.C. Tenover, T.J. White (Eds.).
7. Tang J., Hu M., Lee S., Roblin R. A polymerase chain reaction based method for detecting Mycoplasma/Acholeplasma contaminations in cell culture. J Microbiol Methods 2000, 39:121-126.
8. Kong A., James G., Gordon S., Zelynski A., Glibert G.L. Species-specific PCR for identification of common contaminant mollicutes in cell culture. Appl Environ Microbiol 2001, 67:3195-3200.
9. Milne C., Daas A. Establishment of European Pharmacopoeia Mycoplasma reference strains. Pharmeuropa Bio 2006, 1:57-70.
10. Meier A., Sander P., Bottger E.C. Protocol 4. Elimination of contaminating DNA within PCR reagents. PCR essential techniques 1996, 19. John Wiley & Sons, New York. J.F. Burke (Ed.).
11. Meier A., Persing D.H., Finken M., Bottger E.C. Elimination of contaminating DNA within polymerase chain reagents: implications for general approach to detection of uncultured pathogens. J Clin Microbiol 1993, 31:646-652.
12. ICH Harmonised Tripartite Guideline. Validation of analytical procedures: text and methodology Q2(R1); 2005.
13. United States Pharmacopoeia. Validation of compendial methods. Section 1225.
14. ICH Harmonised Tripartite Guideline. Viral safety evaluation of biotechnology products derived from cell lines of animal or human origin. Q5A (R1); 1997.
15. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.